应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LITS Lite Strategy Inc.
盘后交易 05-28 18:15:02 EDT
1.02
+0.02
+2.00%
盘后
1.03
+0.01
+0.97%
18:03 EDT
最高
1.03
最低
0.9681
成交量
78.10万
今开
0.9935
昨收
1.00
日振幅
6.19%
总市值
3,471万
流通市值
3,112万
总股本
3,403万
成交额
77.71万
换手率
2.56%
流通股本
3,051万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
投资观察 · 2025-11-20
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
美股速递 · 2025-11-17
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
公司概况
公司名称:
Lite Strategy Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。
发行价格:
--
{"stockData":{"symbol":"LITS","market":"US","secType":"STK","nameCN":"Lite Strategy Inc.","latestPrice":1.02,"timestamp":1779998400000,"preClose":1,"halted":0,"volume":780966,"hourTrading":{"tag":"盘后","latestPrice":1.0299,"preClose":1.02,"latestTime":"18:03 EDT","volume":232,"amount":237.6299904,"timestamp":1780005819572,"change":0.0099,"changeRate":0.009706,"amplitude":0.009706},"delay":0,"changeRate":0.020000000000000018,"floatShares":30507399,"shares":34025200,"eps":-2.08,"marketStatus":"盘后交易","change":0.02,"latestTime":"05-28 18:15:02 EDT","open":0.9935,"high":1.03,"low":0.9681,"amount":777086.5904433,"amplitude":0.0619,"askPrice":1.03,"askSize":1285,"bidPrice":1.02,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-2.08,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780012800000},"marketStatusCode":4,"adr":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":1,"preHourTrading":{"tag":"盘前","latestPrice":0.99,"preClose":1,"latestTime":"09:27 EDT","volume":10400,"amount":10351.50064,"timestamp":1779974840643,"change":-0.01,"changeRate":-0.01,"amplitude":0.006},"postHourTrading":{"tag":"盘后","latestPrice":1.0299,"preClose":1.02,"latestTime":"18:03 EDT","volume":232,"amount":237.6299904,"timestamp":1780005819572,"change":0.0099,"changeRate":0.009706,"amplitude":0.009706},"volumeRatio":1.431506,"impliedVol":0.9697,"impliedVolPercentile":0.1404},"requestUrl":"/m/hq/s/LITS/wiki","defaultTab":"wiki","newsList":[{"id":"1189532616","title":"Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1189532616","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189532616?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:58","pubTimestamp":1763575105,"startTime":"0","endTime":"0","summary":"Lite Strategy Inc :: *Lite Strategy公布2026财年第一季度财报,强调成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156188236","title":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","url":"https://stock-news.laohu8.com/highlight/detail?id=1156188236","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156188236?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:01","pubTimestamp":1763388071,"startTime":"0","endTime":"0","summary":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://litestrategy.com","stockEarnings":[{"period":"1week","weight":-0.1071},{"period":"1month","weight":-0.1453},{"period":"3month","weight":-0.1228},{"period":"6month","weight":-0.4709},{"period":"1year","weight":-0.5349},{"period":"ytd","weight":-0.2424}],"compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":0.0493},{"period":"3month","weight":0.0887},{"period":"6month","weight":0.0981},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.05532},{"month":2,"riseRate":0.391304,"avgChangeRate":-0.008473},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.069997},{"month":4,"riseRate":0.521739,"avgChangeRate":0.018779},{"month":5,"riseRate":0.434783,"avgChangeRate":0.031877},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.082941},{"month":7,"riseRate":0.363636,"avgChangeRate":0.076909},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010903},{"month":9,"riseRate":0.52381,"avgChangeRate":0.049595},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.06395},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.039907},{"month":12,"riseRate":0.227273,"avgChangeRate":0.003146}],"exchange":"NASDAQ","name":"Lite Strategy Inc.","nameEN":"Lite Strategy Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lite Strategy Inc.,LITS,Lite Strategy Inc.股票,Lite Strategy Inc.股票老虎,Lite Strategy Inc.股票老虎国际,Lite Strategy Inc.行情,Lite Strategy Inc.股票行情,Lite Strategy Inc.股价,Lite Strategy Inc.股市,Lite Strategy Inc.股票价格,Lite Strategy Inc.股票交易,Lite Strategy Inc.股票购买,Lite Strategy Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}